Bingxiang Wu
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Pulmonary Hypertension Research and Treatments
Papers in
-
- Pulmonary Hypertension Research and Treatments 10
-
- Electric Vehicles and Infrastructure 3
- Smart Grid Energy Management 3
- Co-authors
- Xiaodong Zheng (4 shared papers)Xin Wei (2 shared papers)Yiying Li (2 shared papers)Cui Ma (2 shared papers)Junting Zhang (2 shared papers)Lixin Zhang (2 shared papers)Siyu He (2 shared papers)Xijuan Zhao (2 shared papers)
- Journals
- BMC Cardiovascular Disorders (2 papers)European Heart Journal (2 papers)European Journal of Pharmacology (2 papers)Advanced Science (1 paper)Energy Technology (1 paper)
- Partner nations
- ChinaItalyUnited States
In The Last Decade
Bingxiang Wu
18 papers receiving 219 citations
Peers
Comparison fields: 5 of 45
- Cancer Research 56
- Pulmonary and Respiratory Medicine 82
- Nephrology 13
- Molecular Biology 111
- Energy Engineering and Power Technology 4
Countries citing papers authored by Bingxiang Wu
This map shows the geographic impact of Bingxiang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingxiang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingxiang Wu more than expected).
Fields of papers citing papers by Bingxiang Wu
This network shows the impact of papers produced by Bingxiang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingxiang Wu. The network helps show where Bingxiang Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Bingxiang Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 72 | |
| 2 | 2020 | 55 | |
| 3 | 2024 | 18 | |
| 4 | 2021 | 17 | |
| 5 | 2016 | 8 | |
| 6 | 2021 | 6 | |
| 7 | 2020 | 6 | |
| 8 | 2019 | 6 | |
| 9 | 2024 | 6 | |
| 10 | 2024 | 5 | |
| 11 | 2016 | 5 | |
| 12 | 2025 | 4 | |
| 13 | 2024 | 4 | |
| 14 | 2022 | 2 | |
| 15 | [The efficacy and safety of bosentan therapy for Chinese patients with idiopathic pulmonary arterial hypertension: an open-label, prospective multicenter study]. | 2011 | 2 |
| 16 | 2020 | 1 | |
| 17 | 2020 | 1 | |
| 18 | 2021 | 1 | |
| 19 | 2025 | 0 | |
| 20 | 2024 | 0 |
About Bingxiang Wu
Bingxiang Wu is a scholar working on Pulmonary and Respiratory Medicine, Electrical and Electronic Engineering, Molecular Biology, Physiology and Cardiology and Cardiovascular Medicine, having authored 26 papers that have together received 219 indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (10 papers), Electric Vehicles and Infrastructure (3 papers), Circular RNAs in diseases (3 papers), Adipose Tissue and Metabolism (3 papers), Smart Grid Energy Management (3 papers), Eicosanoids and Hypertension Pharmacology (2 papers), Advanced Battery Technologies Research (1 paper) and Venous Thromboembolism Diagnosis and Management (1 paper). The work is most often cited by research in Cancer Research (56 citations), Pulmonary and Respiratory Medicine (82 citations), Nephrology (13 citations), Molecular Biology (111 citations) and Energy Engineering and Power Technology (4 citations). Bingxiang Wu has collaborated with scholars based in China, Italy and United States. Frequent co-authors include Xiaodong Zheng, Xin Wei, Yiying Li, Cui Ma, Junting Zhang, Lixin Zhang, Siyu He, Xijuan Zhao, Daling Zhu and Yuan Jiang. Their work appears in journals such as BMC Cardiovascular Disorders, European Heart Journal, European Journal of Pharmacology, Advanced Science and Energy Technology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.